Northeast Financial Consultants’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10,130
| Closed | -$101K | – | 364 |
|
|
2022
Q1 | $101K | Sell |
10,130
-1,310
| -11% | -$13.1K | 0.01% | 379 |
|
|
2021
Q4 | $135K | Hold |
11,440
| – | – | 0.01% | 344 |
|
|
2021
Q3 | $130K | Buy |
+11,440
| New | +$130K | 0.01% | 344 |
|
|
2020
Q3 | – | Sell |
-8,290
| Closed | -$210K | – | 306 |
|
|
2020
Q2 | $210K | Buy |
+8,290
| New | +$210K | 0.02% | 264 |
|